2 ms·
It sounds like we need better non-invasive early detection. Tests where you can monitor the progress. Simply saying "we've got some early tests that aren't ver
by melling 10y ago
It sounds like we need better non-invasive early detection. Tests where you can monitor the progress. Simply saying "we've got some early tests that aren't very helpful" doesn't mean we shouldn't be improving the tests.
Also, i'm not sure why we can't have both: better early detection and better treatments.
- shanacarp 10y agoPathways genomics is actually in clinical trials for blood tests to detect very very early masses that won't show up on scans. One of the vps from Google's moonshot division,Jeff Huber, just left to head up a company that is a spinout of illumina, called Grail No affiliation, but they have a bunch of interesting software jobs open after looking at thier site http://newton.newtonsoftware.com/career/CareerHome.action?clientId=8a788267534a42fe0153622849ce068d http://newton.newtonsoftware.com/career/CareerHome.action?cl...